FIELD: chemistry.
SUBSTANCE: novel compounds of formulas , , , , , , (designation of all groups are given in invention formula) are used for treatment of different metabolic diseases, such as insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver, cachexia, obesity, atherosclerosis and arteriosclerosis.
EFFECT: using compounds as biologically active agent and creating pharmaceutical compositions based on said compounds.
124 cl, 52 ex, 17 tbl, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS FOR TREATING METABOLIC DISEASES | 2008 |
|
RU2502723C2 |
COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501554C2 |
COMPOUNDS AND METHODS FOR URIC ACID REDUCTION | 2009 |
|
RU2501555C2 |
COMPOUNDS FOR TREATMENT OF METABOLIC DISORDERS | 2006 |
|
RU2420276C2 |
TETRAZOLE COMPOUNDS FOR REDUCING CONCENTRATION OF URIC ACID | 2009 |
|
RU2522458C2 |
COMPOUND FOR TREATING METABOLIC DISORDERS | 2008 |
|
RU2521284C2 |
COMPOUNDS FOR METABOLIC DISORDER TREATMENT | 2004 |
|
RU2349584C2 |
CARBAMATES, INTERMEDIATE COMPOUNDS, A FUNGICIDE COMPOSITION, A METHOD OF STRUGGLE AGAINST FUNGI | 1993 |
|
RU2129118C1 |
THIOHYDANTOIN DERIVATIVES USEFUL AS ANDROGEN RECEPTOR ANTAGONISTS | 2012 |
|
RU2598854C2 |
DERIVATIVES OF IMIDAZOPYRIDINE, METHOD FOR THEIR PREPARING AND INTERMEDIATE COMPOUNDS, PHARMACEUTICAL PREPARATION BASED ON THEREOF (VARIANTS), METHOD FOR INHIBITION OF GASTRIC ACID SECRETION AND METHOD FOR TREATMENT OF STATES ASSOCIATED WITH HELICOBACTER PYLORI INFECTION | 1999 |
|
RU2235725C2 |
Authors
Dates
2008-12-20—Published
2002-06-12—Filed